RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.

[1]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[2]  D. Tarin,et al.  Integrin αvβ3/c-src “Oncogenic Unit” Promotes Anchorage-independence and Tumor Progression , 2009, Nature Medicine.

[3]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[4]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[5]  Sendurai A Mani,et al.  The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies , 2009, Journal of Mammary Gland Biology and Neoplasia.

[6]  Lesley A. Mathews,et al.  Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature , 2009, Clinical & Experimental Metastasis.

[7]  Y. Ohba,et al.  Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis. , 2009, Cancer research.

[8]  Y. Ohba,et al.  Transcription factor 8 activates R-Ras to regulate angiogenesis. , 2009, Biochemical and biophysical research communications.

[9]  J. Penninger,et al.  RANK/RANKL: Regulators of Immune Responses and Bone Physiology , 2008, Annals of the New York Academy of Sciences.

[10]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[11]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[12]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[13]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[14]  Y. Ohba,et al.  PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. , 2008, Biochemical and biophysical research communications.

[15]  S. Choi,et al.  Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy , 2008, Journal of dental research.

[16]  C. Van Waes,et al.  Role of activated nuclear factor‐κB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck , 2007, Head & neck.

[17]  J. Grandis,et al.  NF-κB Gene Signatures and p53 Mutations in Head and Neck Squamous Cell Carcinoma , 2007, Clinical Cancer Research.

[18]  John M. Wright,et al.  Signal Transduction Pathways Involved in Epithelial-Mesenchymal Transition in Oral Cancer Compared with Other Cancers , 2007, Cells Tissues Organs.

[19]  N. Takano,et al.  Establishment of a murine model of bone invasion by oral squamous cell carcinoma. , 2007, Oral oncology.

[20]  M. Sporn,et al.  The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.

[21]  H. Yoshida,et al.  Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. , 2006, International journal of oncology.

[22]  A. G. Herreros,et al.  Snail-dependent and -independent Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Cells , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  G. Weinstein,et al.  Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[24]  B. Wollenberg,et al.  Role of cytokines in head and neck squamous cell carcinoma , 2006, Expert review of anticancer therapy.

[25]  Robert A. Weinberg,et al.  Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.

[26]  G. Ogden,et al.  Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) -- recent trends and regional variation. , 2006, Oral oncology.

[27]  Y. Shintani,et al.  Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells. , 2006, Molecular biology of the cell.

[28]  Lisa M. Ebert,et al.  Directions in the immune targeting of cancer: Lessons learned from the cancer‐testis Ag NY‐ESO‐1 , 2006, Immunology and cell biology.

[29]  A. Suri.  Cancer testis antigens – their importance in immunotherapy and in the early detection of cancer , 2006, Expert opinion on biological therapy.

[30]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[31]  K. Verschueren,et al.  Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. , 2006, International journal of oncology.

[32]  G. Berx,et al.  The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. , 2005, Cancer research.

[33]  J. Joyce,et al.  Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.

[34]  S. Hashimoto,et al.  Effect of YM529 on a Model of Mandibular Invasion by Oral Squamous Cell Carcinoma in Mice , 2005, Clinical Cancer Research.

[35]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[36]  H. Saya,et al.  Mechanism and biological significance of CD44 cleavage , 2004, Cancer science.

[37]  A. Popovtzer,et al.  Squamous Cell Carcinoma of the Oral Tongue in Young Patients , 2004, The Laryngoscope.

[38]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[39]  N. Johnson,et al.  An analysis of risk factors for oral cancer in young people: a case-control study. , 2004, Oral oncology.

[40]  P. Gaffney,et al.  Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck , 2004, Cancer Research.

[41]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[42]  M. Maio,et al.  Epigenetic targets for immune intervention in human malignancies , 2003, Oncogene.

[43]  J. Shah,et al.  Cyclooxygenase‐2: A novel molecular target for the prevention and treatment of head and neck cancer , 2002, Head & neck.

[44]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[45]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[46]  Y. M. Lee,et al.  TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[47]  P. Reichart,et al.  Identification of risk groups for oral precancer and cancer and preventive measures , 2001, Clinical Oral Investigations.

[48]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[49]  J. Myers,et al.  Cancer of the oral cavity. , 2000, Current problems in surgery.

[50]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[51]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[52]  R. Todd,et al.  Epidermal growth factor receptor (EGFR) biology and human oral cancer. , 1999, Histology and histopathology.

[53]  N. Udagawa,et al.  A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. , 1999, Biochemical and biophysical research communications.

[54]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[55]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Israël,et al.  IκB proteins: structure, function and regulation , 1997 .

[57]  S. Haskill,et al.  Integrin-mediated Tyrosine Phosphorylation and Cytokine Message Induction in Monocytic Cells , 1995, The Journal of Biological Chemistry.

[58]  C. Ostberg,et al.  Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. , 1994, The Journal of biological chemistry.

[59]  C. Rosen,et al.  Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes , 1993 .

[60]  T. Coleman,et al.  Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model , 1993, Molecular and cellular biology.

[61]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[62]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[63]  L. Orci,et al.  Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors , 1991, Cell.

[64]  H. Hiratsuka,et al.  Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity , 1983, Cancer.

[65]  G. Fletcher,et al.  Cancer of the oral cavity , 1970 .

[66]  Izhak Haviv,et al.  Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.

[67]  Josef Gotzmann,et al.  Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. , 2004, Mutation research.

[68]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[69]  N. Kamata,et al.  Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. , 2001, Oral oncology.

[70]  A. Israël,et al.  I kappa B proteins: structure, function and regulation. , 1997, Seminars in cancer biology.

[71]  E. Jimi,et al.  Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. , 1997, Methods in enzymology.

[72]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[73]  J. MontalvoScull.  Incidence of oral and oropharyngeal cancer , 1978 .